Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Yield10 Bioscience Q1 2024 Adj EPS $(4.77) Misses $(2.64) Estimate, Sales $300.00K Miss $1.88M Estimate

Author: Benzinga Newsdesk | May 15, 2024 04:04pm
Yield10 Bioscience (NASDAQ:YTEN) reported quarterly losses of $(4.77) per share which missed the analyst consensus estimate of $(2.64) by 80.68 percent. The company reported quarterly sales of $300.00 thousand which missed the analyst consensus estimate of $1.88 million by 84.00 percent. This is a 400.00 percent increase over sales of $60.00 thousand the same period last year.

Posted In: YTEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist